J. Lasota

Gastroenterology · American Journal of Surgical Pathology · 2000–2022

A researcher in the Science corpus: 10 papers; trusts 2 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Gastroenterology — 34 citations into it; #8 of 63 by trust here, #19 by citations
• Pulmonary and Respiratory Medicine — 15 citations into it; #199 of 770 by trust here, #259 by citations
• Surgery — 14 citations into it; #298 of 1,106 by trust here, #304 by citations

Whom J. Lasota trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Miettinen

Who trusts J. Lasota overall

1. Heikki Joensuu
2. M. Miettinen
3. Christopher Corless

Papers from J. Lasota's perspective

Ordered by how strongly the researchers J. Lasota trusts endorse each paper. Same corpus, a different order for every researcher.

1. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. (American Journal of Pathology)
2. Clinical management of gastrointestinal stromal tumors: before and after STI-571. (Human Pathology)
3. Diagnosis of gastrointestinal stromal tumors: A consensus approach. (Human Pathology)
4. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. (New England Journal of Medicine)
5. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. (Journal of Clinical Oncology)
6. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. (Cancer Research)
7. Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase* (Journal of Biological Chemistry)
8. Genes expressed in human tumor endothelium. (Science)
9. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. (American Journal of Pathology)
10. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. (New England Journal of Medicine)

Their papers

• PRAME EXPRESSION IN CANCER. A SYSTEMATIC IMMUNOHISTOCHEMICAL STUDY OF >5800 EPITHELIAL AND NONEPITHELIAL TUMORS. (2022)
• GATA 3 – A MULTISPECIFIC BUT POTENTIALLY USEFUL MARKER IN SURGICAL PATHOLOGY – A SYSTEMATIC ANALYSIS OF 2500 EPITHELIAL AND NON-EPITHELIAL TUMORS (2014) — 619 citations
• Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. (2009) — 1,425 citations
• Gastrointestinal Stromal Tumors of the Jejunum and Ileum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 906 Cases Before Imatinib With Long-term Follow-up (2006) — 637 citations
• Gastrointestinal stromal tumors: pathology and prognosis at different sites. (2006) — 2,001 citations
• Gastrointestinal Stromal Tumors of the Stomach: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 1765 Cases With Long-term Follow-up (2005) — 1,305 citations
• Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. (2002) — 688 citations
• Diagnosis of gastrointestinal stromal tumors: A consensus approach. (2002) — 3,676 citations
• Gastrointestinal Stromal Tumors, Intramural Leiomyomas, and Leiomyosarcomas in the Duodenum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 167 Cases (2001) — 728 citations
• Gastrointestinal stromal tumors – definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis (2000) — 1,889 citations